CARL Insider Trading Activity and SEC Form 4 Filings
CARL insider trading summary
Over the past 12 months, insiders at Carlsmed, Inc. (CARL) reported 5 sales worth $2.7M by 2 insiders and no open-market purchases on SEC Form 4. Net insider selling was $2.7M.
Latest CARL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Nov 3, 2026 | Jeffrey Bertolini | Chief Operating Officer | Sell | $11K (747 @ $15.15) |
| Oct 30, 2026 | Jeffrey Bertolini | Chief Operating Officer | Sell | $4K (243 @ $15.80) |
| Oct 5, 2026 | Jeffrey Bertolini | Chief Operating Officer | Sell | $11K (747 @ $14.39) |
| Sep 30, 2026 | Jeffrey Bertolini | Chief Operating Officer | Sell | $3K (243 @ $13.99) |
| Mar 2, 2026 | Michael Cordonnier | CEO, President | Sell | $2.6M (197,855 @ $13.29) |
| Jul 24, 2025 | Philip M Young | Insider | Buy | $800K (53,333 @ $15.00) |
| Jul 24, 2025 | Jonathan D Root | Insider | Buy | $7.0M (466,666 @ $15.00) |
| Jul 24, 2025 | Kevin Sidow | Insider | Buy | $200K (13,333 @ $15.00) |
| Jul 24, 2025 | Robert Mittendorff II | Insider | Buy | $20.0M (1,333,333 @ $15.00) |
| Jul 24, 2025 | B Capital Group Management, L.P. | Insider | Buy | $20.0M (1,333,333 @ $15.00) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.